[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ntrk-family-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"NTRK Family Gene",16,15,[8,16,22,29,35,42,48,55,61,67,73,79,86,92,98,104],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04302025","A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)",[12],"Phase 2","RECRUITING","2026-08-26T02:16:08.402952Z","2026-06-16T05:54:07.906610Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT01639508","Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity",[12],"2026-08-26T02:16:01.079019Z","2026-05-05T02:43:29.394895Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06716138","A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors",[26],"Phase 1","2026-08-26T02:15:56.561131Z","2026-05-05T02:43:29.330388Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05456256","A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma",[12],"2026-08-26T02:19:16.454910Z","2026-05-05T02:43:28.856420Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT04655404","A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion",[39],"Early Phase 1","2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.502559Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06307795","A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors",[26],"2026-08-26T02:19:09.651016Z","2026-05-05T02:43:28.368425Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":53,"content_modified":54},"NCT06745908","Randomized, Two-Cohort, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In",[52],"Phase 3","2026-08-26T02:18:42.501841Z","2026-05-05T02:43:28.120702Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT06482905","Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.",[26],"2026-08-26T02:17:41.695983Z","2026-05-05T02:43:28.000760Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT06010342","A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients",[12],"2026-08-26T02:19:29.922117Z","2026-05-05T02:43:27.610502Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT06007924","A Study of Avutometinib and Defactinib in People With Thyroid Cancer",[12],"2026-08-26T02:19:19.162260Z","2026-05-05T02:43:27.103317Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT05783323","Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer",[12],"2026-08-26T02:19:18.331180Z","2026-05-05T02:35:31.906519Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":84,"content_modified":85},"NCT07111520","A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)",[83],"Phase 1\u002FPhase 2","2026-08-26T02:15:39.267524Z","2026-04-29T02:57:57.062678Z",{"nct_id":87,"title":88,"phases":89,"status":13,"updated_at":90,"content_modified":91},"NCT05269381","Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors",[83],"2026-08-26T02:19:10.436356Z","2026-04-29T02:57:57.121665Z",{"nct_id":93,"title":94,"phases":95,"status":13,"updated_at":96,"content_modified":97},"NCT05024929","Targeted Therapy to Increase RAI Uptake in Metastatic DTC",[],"2026-08-26T02:15:44.309045Z","2026-05-13T02:55:06.280918Z",{"nct_id":99,"title":100,"phases":101,"status":13,"updated_at":102,"content_modified":103},"NCT04142437","Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body",[],"2026-08-26T02:15:46.655893Z","2026-05-13T02:55:06.241374Z",{"nct_id":105,"title":106,"phases":107,"status":108,"updated_at":109,"content_modified":110},"NCT06074588","Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)",[52],"ACTIVE_NOT_RECRUITING","2026-08-03T02:08:28.425355Z","2026-05-05T02:35:31.905794Z"]